Read the full stored bill text
S3321
SENATE, No. 3321
STATE OF NEW JERSEY
222nd LEGISLATURE
�
INTRODUCED FEBRUARY 5, 2026
Sponsored by:
Senator� SHIRLEY K. TURNER
District 15 (Hunterdon and Mercer)
SYNOPSIS
���� Requires DHS to implement payment strategy to
encourage use of long acting reversible contraceptives.
CURRENT VERSION OF TEXT
���� As introduced.
��
An Act
requiring the Department of Human Services to implement
a
payment strategy for Medicaid clients and supplementing Title 30 of
the Revised Statutes.
����
Be It
Enacted
by the Senate and General Assembly of
the State of New Jersey:
���� �1.�� a.� The Department of
Human Services shall implement a State Medicaid payment strategy to optimize
the availability of long acting reversible contraceptives.� The payment
strategy shall include, but not be limited to, the following initiatives:
���� (1)�� provide timely,
patient-centered comprehensive coverage for the provision of long acting
reversible contraceptives for women;
���� (2)�� reimburse for immediate
postpartum insertion of long acting reversible contraceptives separate from
other labor and delivery services;
���� (3)�� remove logistical
barriers for supply management of long acting reversible contraceptive devices;
and
���� (4)�� remove administrative
barriers for provision of long acting reversible contraceptive devices.
���� b.��� The department shall
require all managed care organizations which provide health care coverage to
Medicaid clients to implement payment strategies as provided in subsection a.
of this section to improve access to and availability of long acting reversible
contraceptive devices for women.
���� 2.��� The Commissioner of
Human Services shall apply for such State plan amendments or waivers as may be
necessary to implement the provisions of this act and to secure federal
financial participation for State Medicaid expenditures under the federal
Medicaid program.
���� 3.��� This act shall take
effect immediately.
STATEMENT
���� This bill would require the
Department of Human Services to implement payment strategies to encourage the
use of long acting reversible contraceptives (LARCs).
���� The payment strategy is
required to include, but not be limited to, the following initiatives:
���� (1)�� provide timely,
patient-centered comprehensive coverage for the provision of LARCs for women;
���� (2)�� reimburse for immediate
postpartum insertion of LARCs separate from other labor and delivery services;
���� (3)�� remove logistical
barriers for supply management of LARC devices; and
���� (4)�� remove administrative
barriers for provision of LARC devices.
���� Furthermore, the bill would
require the department to ensure that the managed care organizations which
provide health insurance coverage for a vast majority of Medicaid clients also
implement these strategies.
���� Nationally, the Center for
Medicaid & CHIP Services launched the Maternal and Infant Health Initiative
in July 2014 to improve maternal and infant health outcomes.� One goal of the
initiative was to increase access and use of effective methods of contraception.�
The federal Centers for Disease Control and Prevention identified LARCs as
among the most effective family planning methods, with pregnancy rates of fewer
than 1 pregnancy per 100 women in the first year. Yet, the use of LARCs in the
United States is relatively low when compared to other countries.� Two reasons
cited for the low utilization of LARCs in the United States are administrative
and reimbursement barriers that result in high upfront costs for devices, and
payment policies that reduce (or do not provide) reimbursement for devices or
placement.�
���� This bill is intended to
motivate the department to adopt policies to increase access and availability
of LARCs to State Medicaid clients.